Cipla Global Ltd.: Generics versus Drug Discovery
CASE STUDY. Thanks to India’s process patent regime (1970–2005), Dr. Yusuf Hamied, the company’s chairman, managed to catapult the company to its position as a leading generics manufacturer.
V.S. Pai
V.S. Pai is professor at Kirloskar Institute of Advanced Management Studies (India).
Expertise: Business Strategy, Corporate Strategy, International Business, Organization Structure and Design and Management Control Systems